FDA Amends Moderna, Pfizer EUAs to Simplify Use of Bivalent COVID-19 Vaccines
Drug Topics
APRIL 18, 2023
Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.
Drug Topics
APRIL 18, 2023
Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.
Pharmacy Times
APRIL 18, 2023
Atogepant (Qulipta; AbbVie) is the first and only oral calcitonin gene-related peptide receptor antagonist to gain FDA approval for the prevention of episodic and chronic migraine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
APRIL 18, 2023
Define Ventures raises $460M to invest in early-stage digital health startups hlandi Tue, 04/18/2023 - 09:23
Pharmacy Times
APRIL 18, 2023
Social media can be an excellent tool to provide education and build your own brand, but professionalism and appropriateness are paramount.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 18, 2023
BRISTOL, Tenn. — Zoe Poplin cupped her hands around her 17-month-old’s head, as if her palms over his ears could protect him. “I’m worried about him,” she said. She stroked baby Ezra’s back. “Because when they’re little, you know, their little cells are splitting real fast, and he’s growing and all it takes is one misreading, and he could end up with childhood cancer.
Pharmacy Times
APRIL 18, 2023
The treatment from Keytruda and Merck shows a clinical response of 89% for individuals with unresectable metastatic desmoplastic melanoma.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 18, 2023
A new scientific statement from the American Heart Association notes that the process falls short for those who are not white.
Drug Store News
APRIL 18, 2023
Of particular importance is the December 2024 extension providing pharmacy clinicians the ability to provide COVID-19 vaccinations, tests and flu shots.
Pharmacy Times
APRIL 18, 2023
Findings show that study participants experienced improvements in both blood sugar control and the lipid profile.
STAT
APRIL 18, 2023
Over the past five years, digital mental health has risen from a niche topic to a global health priority. Patients, researchers, regulators, and investors alike are thrilled by the potential of ubiquitous mobile technology like smartphones to help diagnose problems, monitor health, and even deliver evidence-based therapies. Two companies that came to embody this potential were Mindstrong for smartphone monitoring of mental health and Pear Therapeutics for FDA-approved apps and digital interventi
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 18, 2023
The Apothecary Shoppe in Utah knows patients by name, garners new business via word of mouth.
Pharmaceutical Technology
APRIL 18, 2023
IntelGenx Corp announced that the US Food and Drug Administration (FDA) has approved the company’s Rizafilm VersaFilm new drug application (NDA) for the treatment of acute migraine. The approval was based on successful results from a bioequivalence study comparing Rizafilm to Merck and Co’s Maxalt-MTL and the European reference Maxalt-Lingua. Rizaport and Maxalt are different formulations of Rizatriptan benzoate.
STAT
APRIL 18, 2023
People ages 65 and older and those who are immunocompromised will be allowed to receive an additional dose of Covid-19 vaccine this spring if they wish, the Food and Drug Administration announced Tuesday. In authorizing another dose for people in these demographics, the agency is following in the footsteps of Canada and the United Kingdom, which earlier announced that older adults, adults who live in care facilities, and people who are immunocompromised would have access to an additional booster
Pharmacy Times
APRIL 18, 2023
Multicancer early detection test could detect cancer with an AUC of 0.94 for all cancer types and stages.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
APRIL 18, 2023
A hospital in Idaho recently announced it will shutter its labor and delivery services due to doctors’ unwillingness to practice medicine in the face of the state’s restrictive and punitive laws surrounding reproductive health care. This comes on the heels of a hospital in rural Washington state closing its labor and delivery services due to concerns over the cost of these services.
Pharmacy Times
APRIL 18, 2023
Durvalumab lowered the risk of death by 32% in patients with non-small cell lung cancer compared to chemotherapy alone.
Fierce Healthcare
APRIL 18, 2023
AWS notches partnerships with 3M, Philips as it strengthens foothold in healthcare cloud, AI hlandi Tue, 04/18/2023 - 15:01
PharmaVoice
APRIL 18, 2023
How an “international” childhood sent Dr. José Trevejo, Tarsus’s chief medical officer, on a mission to fight infectious diseases.
Drug Store News
APRIL 18, 2023
The report found that older adults seeking health care have more confidence in their pharmacist (55%) and primary care provider (65%) than any other age group.
Fierce Healthcare
APRIL 18, 2023
Report: Hospitals, payers making strides on price transparency compliance dmuoio Tue, 04/18/2023 - 09:49
Drug Store News
APRIL 18, 2023
Residents in Baltimore City with SNAP and EBT benefits can save on produce accessible through Giant Pickup and Giant Delivers orders.
Fierce Healthcare
APRIL 18, 2023
HIMSS23: Google proceeds with caution in piloting its LLM in healthcare aburky Tue, 04/18/2023 - 17:52
Drug Store News
APRIL 18, 2023
Relove by Revolution will offer eyebrow and foundation collections and trend-driven products priced at $5 or less, the company said.
Fierce Healthcare
APRIL 18, 2023
No Surprises Act largely successful in protecting consumers though gaps remain, stakeholders say dmuoio Tue, 04/18/2023 - 15:18
Drug Store News
APRIL 18, 2023
Traditional OTC pain relievers remain popular, but topical and natural solutions are gaining traction.
Fierce Pharma
APRIL 18, 2023
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A aarmstrong Tue, 04/18/2023 - 09:47
Drug Store News
APRIL 18, 2023
Blue Bunny’s new launches include Mini Bars, Soft Scoopables and two new flavors additions to its Twist Cones line.
Fierce Pharma
APRIL 18, 2023
AbbVie's Qulipta gains edge on Pfizer's Nurtec with FDA approval to prevent chronic migraines zbecker Tue, 04/18/2023 - 11:09
Drug Store News
APRIL 18, 2023
Residents in Baltimore City with SNAP and EBT benefits can save on produce accessible through Giant Pickup and Giant Delivers orders.
European Pharmaceutical Review
APRIL 18, 2023
GSK has agreed to acquire late-stage biopharma BELLUS Health, for a total of £1.6 billion. The proposed acquisition will give GSK access to camlipixant, a highly selective P2X3 antagonist for first-line treatment of adults with refractory chronic cough (RCC). “This proposed acquisition builds on our expertise in respiratory therapies,” commented Luke Miels, Chief Commercial Officer at GSK.
Fierce Pharma
APRIL 18, 2023
Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi esagonowsky Tue, 04/18/2023 - 08:25
Pharmacy Times
APRIL 18, 2023
Substantial strides have been made in the management of Ph+ ALL.
Drug Store News
APRIL 18, 2023
The venture is focused on improving access to affordable primary and specialty care in rural communities.
Fierce Pharma
APRIL 18, 2023
Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48
Let's personalize your content